Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Sejersten Ripa

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Danish Medical Journal|March 3, 2012
The ECG as decision support in STEMIMaria Sejersten Ripa
Diabetes, Obesity & Metabolism|February 19, 2021
Applying REWIND cardiovascular disease criteria to SUSTAIN 6 and PIONEER 6: An exploratory analysis of cardiovascular outcomes with semaglutideSubodh Verma, Udi Fainberg, Mansoor Husain, et al.
Ugeskrift for Laeger|March 21, 2006
[Telemedicine in the transmission of prehospitalisation ECGs of patients with suspected acute myocardial infarction]Martin Sillesen, Maria Sejersten Ripa, Søren Strange, et al.
Scandinavian Cardiovascular Journal : SCJ|March 30, 2018
Correlation of ST changes in leads V4-V6 to area of ischemia by CMR in inferior STEMIXiaoming Jia, Einar Heiberg, Maria Sejersten Ripa, et al.
Cardiology|August 13, 2018
Cardiac Magnetic Resonance Evaluation of the Extent of Myocardial Injury in Patients with Inferior ST Elevation Myocardial Infarction and Concomitant ST Depression in Leads V1-V3: Analysis from the MITOCARE StudyXiaoming Jia, Einar Heiberg, Maria Sejersten Ripa, et al.
Diabetes, Obesity & Metabolism|March 25, 2022
Cardiovascular efficacy of liraglutide and semaglutide in individuals with diabetes and peripheral artery diseaseSubodh Verma, Mohammed Al-Omran, Lawrence A Leiter, et al.
Stroke|May 18, 2022
Effects of Semaglutide on Stroke Subtypes in Type 2 Diabetes: Post Hoc Analysis of the Randomized SUSTAIN 6 and PIONEER 6W David Strain, Ofir Frenkel, Martin A James, et al.
Annals of Noninvasive Electrocardiology : the Official Journal of the International Society for Holter and Noninvasive Electrocardiology, Inc|June 28, 2020
Worst lead ST deviation and resolution of ST elevation at one hour for prediction of myocardial salvage, infarct size, and microvascular obstruction in patients with ST-elevation myocardial infarction treated with primary percutaneous coronary interventionAnne Line Stensjøen, Anders Hommerstad, Sigrun Halvorsen, et al.
Diabetes, Obesity & Metabolism|May 7, 2020
The effect of glucagon-like peptide-1 receptor agonists liraglutide and semaglutide on cardiovascular and renal outcomes across baseline blood pressure categories: Analysis of the LEADER and SUSTAIN 6 trialsLawrence A Leiter, Stephen C Bain, Deepak L Bhatt, et al.
Diabetes, Obesity & Metabolism|July 10, 2020
Impact of microvascular disease on cardiovascular outcomes in type 2 diabetes: Results from the LEADER and SUSTAIN 6 clinical trialsSubodh Verma, Stephen C Bain, Julie Broe Honoré, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Danish Medical Journal|March 3, 2012
The ECG as decision support in STEMIMaria Sejersten Ripa
Diabetes, Obesity & Metabolism|February 19, 2021
Applying REWIND cardiovascular disease criteria to SUSTAIN 6 and PIONEER 6: An exploratory analysis of cardiovascular outcomes with semaglutideSubodh Verma, Udi Fainberg, Mansoor Husain, et al.
Ugeskrift for Laeger|March 21, 2006
[Telemedicine in the transmission of prehospitalisation ECGs of patients with suspected acute myocardial infarction]Martin Sillesen, Maria Sejersten Ripa, Søren Strange, et al.
Scandinavian Cardiovascular Journal : SCJ|March 30, 2018
Correlation of ST changes in leads V4-V6 to area of ischemia by CMR in inferior STEMIXiaoming Jia, Einar Heiberg, Maria Sejersten Ripa, et al.
Cardiology|August 13, 2018
Cardiac Magnetic Resonance Evaluation of the Extent of Myocardial Injury in Patients with Inferior ST Elevation Myocardial Infarction and Concomitant ST Depression in Leads V1-V3: Analysis from the MITOCARE StudyXiaoming Jia, Einar Heiberg, Maria Sejersten Ripa, et al.
Diabetes, Obesity & Metabolism|March 25, 2022
Cardiovascular efficacy of liraglutide and semaglutide in individuals with diabetes and peripheral artery diseaseSubodh Verma, Mohammed Al-Omran, Lawrence A Leiter, et al.
Stroke|May 18, 2022
Effects of Semaglutide on Stroke Subtypes in Type 2 Diabetes: Post Hoc Analysis of the Randomized SUSTAIN 6 and PIONEER 6W David Strain, Ofir Frenkel, Martin A James, et al.
Annals of Noninvasive Electrocardiology : the Official Journal of the International Society for Holter and Noninvasive Electrocardiology, Inc|June 28, 2020
Worst lead ST deviation and resolution of ST elevation at one hour for prediction of myocardial salvage, infarct size, and microvascular obstruction in patients with ST-elevation myocardial infarction treated with primary percutaneous coronary interventionAnne Line Stensjøen, Anders Hommerstad, Sigrun Halvorsen, et al.
Diabetes, Obesity & Metabolism|May 7, 2020
The effect of glucagon-like peptide-1 receptor agonists liraglutide and semaglutide on cardiovascular and renal outcomes across baseline blood pressure categories: Analysis of the LEADER and SUSTAIN 6 trialsLawrence A Leiter, Stephen C Bain, Deepak L Bhatt, et al.
Diabetes, Obesity & Metabolism|July 10, 2020
Impact of microvascular disease on cardiovascular outcomes in type 2 diabetes: Results from the LEADER and SUSTAIN 6 clinical trialsSubodh Verma, Stephen C Bain, Julie Broe Honoré, et al.
Pageof 2